Insmed (INSM) FCF Margin (2011 - 2026)

Insmed (INSM) posted quarterly FCF Margin of 73.94% for Q1 2026, up 21926.0% year-over-year from N/an in Q1 2025, and up 24.79% quarter-over-quarter from 98.31% in Q4 2025.

Insmed (INSM) FCF Margin (2011 - 2026) Analysis & Trends

Insmed's FCF Margin history runs 11 years deep, the most recent figure standing at 73.94% for Q1 2026.

  • In Q1 2026, FCF Margin rose 21926.0% year-over-year to 73.94%; the TTM figure through Mar 2026 stood at 108.74% (up 9177.0% YoY), while the FY2025 annual figure was 154.54%, up 3120.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 73.94%, up from 98.31% in the prior quarter.
  • The five-year high for FCF Margin was 73.94% in Q1 2026, with the low at 293.2% in Q1 2025.
  • The 5-year median for FCF Margin is 168.64% (2022), against an average of 173.88%.
  • The sharpest annual moves came in 2025 and 2026: FCF Margin tumbled 7553 bps in 2025, then surged 21926 bps in 2026.
  • Insmed's FCF Margin stood at 168.64% in 2022, then increased by 6 bps to 158.88% in 2023, then dropped by 16 bps to 185.05% in 2024, then soared by 47 bps to 98.31% in 2025, then increased by 25 bps to 73.94% in 2026.
  • Business Quant data shows INSM's FCF Margin at 73.94% in Q1 2026, 98.31% in Q4 2025, and 138.08% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 13.35%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 25.68%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -77,594.17%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 70.82%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 22.62%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -22.35%
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -18,629.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.35%
Mar 31, 2026 -73.94%
Dec 31, 2025 -98.31%
Sep 30, 2025 -138.08%
Jun 30, 2025 -194.62%
Mar 31, 2025 -293.20%
Dec 31, 2024 -185.05%
Sep 30, 2024 -204.43%
Jun 30, 2024 -119.09%
Mar 31, 2024 -243.31%
Dec 31, 2023 -158.88%
Sep 30, 2023 -177.07%
Jun 30, 2023 -164.25%
Mar 31, 2023 -229.55%
Dec 31, 2022 -168.64%
Sep 30, 2022 -145.06%
Jun 30, 2022 -161.31%
Mar 31, 2022 -201.22%
Dec 31, 2021 -182.49%
Sep 30, 2021 -164.52%